Exclusive: Stellantis resurrects diesel cars across Europe amid EV retreat
Reuters· 2026-02-13 13:08
[Businesscategory] [TotalEnergies booked loss in France due to refining activities, CEO says][Financecategory] [Former Citigroup unit in Russia says it is changing its name to RenCap Bank] Exclusive: Stellantis resurrects diesel cars across Europe amid EV retreat | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]Vauxhall Combo-e, Citroen e-Berlingo and Peugeot e-Rifter are pictured at Vauxhall car factory in Ellesmere Port, Britain J ...
I Wouldn't Want To Retire Without The 3 Most Undervalued Income Machines
Seeking Alpha· 2026-02-13 13:08
Core Insights - High Yield Investor is celebrating its fifth anniversary by offering a 30-day money-back guarantee, encouraging new memberships and promoting its Top Picks for 2026 [1] - The investment strategy focuses on building a diversified portfolio of high-yielding, high-quality businesses with strong balance sheets and sustainable yields, aimed at generating passive income for retirement [1] Company Background - Samuel Smith, the lead analyst and Vice President, has extensive experience in dividend stock research and holds advanced degrees in engineering and mathematics [1] - The High Yield Investor team includes Samuel Smith, Jussi Askola, and Paul R. Drake, who work together to balance safety, growth, yield, and value in their investment approach [1] Service Offerings - High Yield Investor provides various portfolios including core, retirement, and international options, along with regular trade alerts and educational content [1] - The service features an active chat room for investors to engage and share insights [1]
Bond Advances Toward Its Largest Enterprise-Wide Deployment to Date Following Successful Paid Pilot with One of the World’s Largest Employers
Globenewswire· 2026-02-13 13:07
Core Insights - The company, Bond, has successfully completed a one-year paid pilot with a major employer in the U.S. with nearly one million employees, leading to discussions for a broader rollout that could generate over $10 million in annual revenue [2][3]. Company Overview - Bond is the creator of the world's first AI-powered Preventative Personal Security platform, which has been adopted by leading multinational companies [2]. - The company has invested over $100 million in technology, operations, and global expansion [9]. Pilot Program Results - The pilot program validated Bond's capability to provide proactive personal security across a large employee base, offering 24/7 access to its platform and live Personal Security Agents [4]. - Feedback from participants was overwhelmingly positive, indicating the platform's scalability and its ability to enhance employees' sense of safety [5]. Future Growth Strategy - Large enterprise deployments are viewed as a core growth pillar for Bond, as major employers are incentivized to implement scalable safety solutions [7]. - The company is in active discussions with additional Fortune 500 companies to expand its offerings [6][8]. Global Presence - Bond operates in 28 countries and has supported over 1.4 million security service requests, including more than 10,000 emergencies [10].
Bond Advances Toward Its Largest Enterprise-Wide Deployment to Date Following Successful Paid Pilot with One of the World's Largest Employers
Globenewswire· 2026-02-13 13:07
Proposed Expansion Across 1M+ U.S. Employees Could Generate Over $10M in Annual Revenue Bond Is in Active Discussions with Additional Fortune 500 Companies NEW YORK, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Our Bond (“Bond”) (legal name: Tg-17, Inc.) (NASDAQ: OBAI), creator of the world’s first AI-powered Preventative Personal Security platform adopted by leading multinational companies, today announced the successful completion of a one-year, paid pilot with one of the world’s largest employers—an organization wi ...
PNC Launches Monthly Consumer Health Check to Deliver Real-Time Pulse on U.S. Spending and the Economy
Prnewswire· 2026-02-13 13:05
Core Insights - PNC Financial Services Group has launched the PNC Monthly Consumer Health Check, providing real-time insights into U.S. consumer activity and the economy [1] - The report utilizes PNC's proprietary, anonymized data to offer actionable insights for business leaders, investors, and households [1] Group 1: Report Features - The Monthly Consumer Health Check will be published monthly, focusing on consumer spending trends, transaction volumes, savings, cash flow patterns, and employment trends [1] - It includes commentary from PNC economists on growth, inflation, and risk assets, as well as readouts on household financial posture [1] - The report breaks down spending trends across essential categories (groceries, fuel), discretionary categories (dining, travel), and emerging trends like gambling and AI [1] Group 2: Methodology and Privacy - The report is produced by aggregating and anonymizing internal data sources, ensuring robust privacy safeguards and seasonal adjustments [1] - The index is benchmarked to a neutral base period to facilitate interpretation of month-to-month changes without accessing personally identifiable information [1] Group 3: Company Overview - PNC Financial Services Group is one of the largest diversified financial services institutions in the U.S., offering a range of retail and business banking services, corporate banking, real estate finance, and wealth management [1]
CPI report, AI disruption sell-off, EPA rollback and more in Morning Squawk
CNBC· 2026-02-13 13:04
This is CNBC's Morning Squawk newsletter. Subscribe here to receive future editions in your inbox.Happy Friday. Remember that Ring Super Bowl commercial, the one about finding the lost dog? Turns out it didn't quite have the effect the Amazon-owned doorbell company was hoping for.Stock futures are down this morning, following a negative session for all three major averages.Here are five key things investors need to know to start the trading day:Traders work on the floor at the New York Stock Exchange (NYSE) ...
Alto Neuroscience Announces Completion of Enrollment in Phase 2 Proof-of-Concept Study of ALTO-101 in Cognitive Impairment Associated with Schizophrenia
Businesswire· 2026-02-13 13:04
Core Viewpoint - Alto Neuroscience, Inc. has completed patient enrollment in its Phase 2 proof-of-concept clinical trial for ALTO-101, targeting cognitive impairment associated with schizophrenia [1] Company Summary - Alto Neuroscience is a clinical-stage biopharmaceutical company focused on developing novel precision medicines for neuropsychiatric disorders [1] - The company is evaluating ALTO-101, a transdermal phosphodiesterase-4 (PDE4) inhibitor, in its clinical trial [1] Industry Context - The trial aims to address cognitive impairment associated with schizophrenia, a significant area of need in neuropsychiatric treatment [1]
Buy 5 IDEAL S&P 600 Small/MidCap 'Safer' February DiviDogs
Seeking Alpha· 2026-02-13 13:01
Group 1 - The article promotes a live video series on Facebook called the Underdog Daily Dividend Show, which highlights potential investment candidates in the S&P 600 Small/MidCap Dividend sector [1] - The show encourages audience engagement by inviting comments on favorite, least favorite, or mysterious stock tickers for future reports [1]
Enbridge Files 2025 Year End Disclosure Documents
Prnewswire· 2026-02-13 13:01
Core Viewpoint - Enbridge Inc. has filed its Form 10-K for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission, along with its audited Consolidated Financial Statements and Management's Discussion and Analysis with Canadian regulatory authorities [1]. Group 1: Financial Reporting - Enbridge's Form 10-K and related financial documents are available electronically on the SEC and Canadian securities regulatory websites, as well as on the company's own website [1]. - Printed copies of the Consolidated Financial Statements and Management's Discussion and Analysis can be requested free of charge [1]. Group 2: Corporate Overview - Enbridge connects millions to energy through its North American natural gas, oil, and renewable power networks, and is expanding its European offshore wind portfolio [1]. - The company is investing in modern energy delivery infrastructure and advancing technologies such as hydrogen, renewable natural gas, and carbon capture and storage [1]. - Enbridge's common shares are traded under the symbol ENB on both the Toronto (TSX) and New York (NYSE) stock exchanges [1]. Group 3: Upcoming Events - Enbridge's Annual Meeting of Shareholders is scheduled to be held virtually on May 6, 2026, at 1:30 p.m. (MT) [1].
Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution
Businesswire· 2026-02-13 13:01
Core Insights - Veradigm has launched a new patient-reported outcomes (PRO) survey capability that integrates patient insights into real-world evidence generation, enhancing the context of clinical and observational research [1] - The solution is built on Veradigm's FollowMyHealth platform, allowing patients to securely share their experiences, which helps life sciences organizations gain a holistic view of patient experiences and outcomes [1] - The integration of patient-reported information with existing real-world data provides a fuller picture of symptom burden, treatment experience, adherence, and quality-of-life factors [1] Company Overview - Veradigm is a leading provider of clinical and revenue cycle solutions for independent practices, with a focus on improving outcomes and financial performance [1] - The company has a proven history of delivering AI-forward data and technology solutions that connect over 20,000 provider practices with health plans and biopharma [1] - Veradigm's solutions are designed to eliminate inefficiencies, close care gaps, and create a more affordable health system [1] Product Features - The new PRO survey capability includes integrated consent and compensation to reduce friction in patient participation [1] - It employs precision outreach to relevant patient groups and ensures trusted engagement through an established patient platform [1] - The solution aims to provide connected clinical and patient input for richer context, capturing patient-centered insights often missing from clinical documentation [1]